Press Release: BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
RESEARCH TRIANGLE PARK, N.C., June 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence showing that patients with hereditary angioedema (HAE) who have normal C1-inhibitor (HAE-nC1-INH) level and function had a reduction in monthly attack rates after starting oral, once-daily ORLADEYO® (berotralstat). The data were presented at the European Academy of Allergy…
Press Release: BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment - Newscast
Sat, 19 Oct 2024 17:00:00 GMT Does your organization or business have an announcement to promote? The Marietta Daily Journal's self-service Press Release Portal can get your organization's announcement the placement it needs.
Thu, 17 Oct 2024 17:00:00 GMT Planegg/Martinsried, October 17, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR) ...
Mon, 14 Oct 2024 17:00:00 GMT NEW YORK – October 15, 2024 — Uniqode (formerly Beaconstac), the highest-ranked QR code platform on G2, today announced three significant product updates designed to enhance user experience, improve ...
Tue, 01 Oct 2024 09:00:00 GMT SUMMIT, N.J., Oct. 1, 2024 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), today announced data from a range of real-world evidence ... www.CSL.com. This press release is issued ...
Mon, 30 Sep 2024 17:00:00 GMT In this section, you’ll find the latest Forbes press releases and news announcements. The collective wealth of India’s 100 Richest on the 2024 Forbes list surpassed the trillion-dollar mark ...
